Default Category
-
When Does Leadership Matter: A Contingent Opportunities View of CEO Leadership
Wasserman, Noam; Anand, Bharat N.; Nohria, NitinBook Chapter HBS-6122BC-ELeadership and People ManagementTo what extent does leadership influence organizational performance? In this chapter, Noam Wasserman, Bharat Anand, and Nitin Nohria try to provide a balanced answer to this question. Replicating the variance partitioning method used by Stanley Lieberson and James O'Connor in their 1972 study on leadership and organizational performance, they analyze the performance of more than 500 publicly held U.S. companies (across 42 industries) over a 20-ye...Starting at €8.20
-
Expansion Strategy (Spanish version)
Sasser, W. Earl, Jr.; Kazan, BrentCase HBS-412S09Service Management, Operations Management, Aggregate Planning, Capacity Planning, Pricing Strategy, Production Controls, Seasonal Demand and Resort ManagementStarting at €8.20
-
Capital One Financial Corp. (Spanish version)
Anand, Bharat N.; Rukstad, Michael G.; Paige, Christopher H.Case HBS-702S01StrategyDesigned to explore the structure, implementation, and sustainability of an information-based strategy (IBS) undertaken by Capital One during the 1990s. Particular issues of interest are the impact of mass customization on industry structure, the ability to transfer IBS skills to new sectors, and the impact of the Internet on industry structure and competitor strategies.Starting at €8.20
-
The Random House Response to the Kindle
Anand, Bharat N.; Olson, Peter W.Case HBS-710444-EStrategyIn early 2010, e-readers like Amazon's Kindle, and Apple's impending iPad, threatened to disrupt the book publishing industry. The case provides an overview of the industry, describes the broader trends regarding e-readers, and asks: how should major publishers like Random House respond to these trends?Starting at €8.20
-
TD Canada Trust (B): Linking the Service Model to the P&L
Campbell, Dennis; Kazan, BrentCase HBS-108043-EStarting at €5.74
-
Strategies of Related Diversification (Spanish version)
Anand, Bharat N.Case HBS-715S23StrategyWhich businesses should a firm expand into? This question of corporate scope is central to corporate strategy. Flawed scope decisions can have severe consequences, and the trauma experienced by many companies as a result of mistaken decisions to expand scope is often large. What leads to such mistakes? Where do managers go wrong? And, what might be a sensible logic by which to approach the question of scope expansion? Examines these questions and...Starting at €8.20
-
TD Canada Trust (C): Translating the Service Model to Service Operations
Campbell, Dennis; Kazan, BrentCase HBS-108055-EStarting at €5.74
-
TD Canada Trust
Campbell, Dennis; Kazan, BrentCase HBS-110049-EAccounting and ControlThe case illustrates the role of performance measurement and analytics in translating TD-Canada Trust's service model of "comfortable banking" into operational terms. In 2000, in a banking market where consumers and regulators were typically hostile to mergers and acquisitions, Canada's fifth largest commercial bank, Toronto-Dominion Bank (TD Bank), undertook a merger with a relatively small trust company, Canada Trust, which was known for except...Starting at €8.20
-
Playa Dorada Tennis Club: Expansion Strategy
Sasser, W. Earl, Jr.; Kazan, BrentCase HBS-4221-EService and Operations ManagementWhen students have the English-language PDF of this Brief Case in a coursepack, they will also have the option to purchase an audio version. Playa Dorada Beach & Resort in Boca Raton, Florida, faces a growing seasonal demand for tennis services. The number of guests is expected to double in the next few years, and while the tennis facilities are a popular and well-promoted amenity at the resort, court space is limited. The director of tennis oper...Starting at €8.20
-
Vertex Pharmaceuticals and the Cystic Fibrosis Foundation: Venture Philanthropy Funding for Biotech
Higgins, Robert F.; Kazan, BrentCase HBS-808005-EFinanceIn 2001, Vertex Pharmaceuticals Incorporated acquired the San Diego-based biotech company, Aurora Biosciences. The combination of Vertex's and Aurora's technologies would improve the flow of novel drug candidates into development. However, several questions related to the integration of Aurora into Vertex were still unresolved, the most pressing being Aurora's major collaboration with the Cystic Fibrosis Foundation (CFF). Were venture philanthrop...Starting at €8.20